Research & development

Starpharma tech applied to AstraZeneca cancer drug

08 April, 2014

Melbourne-based biotech company Starpharma has signed an expanded agreement with biopharma company AstraZeneca in the field of cancer medicine. The new agreement will see the application of Starpharma's dendrimer technology to a cancer drug from AstraZeneca's pipeline.


Botox may smooth out depression

03 April, 2014

Researchers have conducted the largest randomised, double-blind, placebo-controlled study to date on the effect of OnabotulinumtoxinA (OBA, or Botox) on depression.


Computer models reveal the impact of continental collisions

25 March, 2014

An international research project has uncovered new evidence about the formation of Earth. The study is the result of more than 10 years' work by scientists from Monash University, The University of Melbourne, the University of Southern California and the Geological Survey of Victoria.


Diagnostic device meets malaria field evaluation objective

25 March, 2014 | Supplied by: Fio Corporation

Fio Corporation's Deki Reader - a mobile in vitro diagnostic device - has demonstrated consistent interpretation of rapid diagnostic tests (RDTs) for multiple malaria strains in a field evaluation.


Patrys antibody shows promise in blood cancers

25 March, 2014

Clinical-stage biotechnology company Patrys has released an update on the development program for its anticancer product PAT-LM1. The company's most recent laboratory experiments evaluated the efficacy of PAT-LM1 in blood cancers, including different types of leukaemias and lymphomas.


Statins slow the progression of advanced MS

24 March, 2014

A study led by Imperial College London has found that statins may provide doctors with a way to slow the progression of multiple sclerosis (MS).


Millennium-old frozen moss comes back to life

21 March, 2014

Researchers from the British Antarctic Survey and the University of Reading have demonstrated for the first time that after over 1500 years frozen in Antarctic ice, moss can come back to life and continue to grow.


First evidence of cosmic inflation found

21 March, 2014

Researchers from the BICEP2 collaboration have announced the first direct evidence of cosmic inflation - the rapid expansion of the universe which immediately followed the Big Bang. Until now, the idea of this exponential expansion was just a theory.


Turning the spotlight on breast cancer cells

20 March, 2014

Scientists are using the latest in nano-flare technology to detect breast cancer cells early on.


Drug testing with synthetic livers

19 March, 2014

Scientists from clinical intelligence company Empiriko have developed chemosynthetic liver technology which could enable the testing of drug candidates without using animals.


Strings of galaxies found in empty space

11 March, 2014

Australian astronomers have discovered short, delicate strings of faint galaxies in what were previously thought to be extremely empty parts of space.


Biomarkers reveal short-term risk of death

05 March, 2014

Researchers from Finland and Estonia have discovered novel biological markers that indicate an individual's risk of dying from any disease in the near future.


Genomic technique identifies origin of plant material

05 March, 2014

Scientists at the Royal Botanic Garden, Sydney, have adapted innovative genomic techniques that allow the accurate identification of the exact origin of plant material.


Program to reintroduce disease-free devils

26 February, 2014

San Diego Zoo Global and the University of Sydney are collaborating to save the Tasmanian devil. The institutions are working on the reintroduction and management of a population free of devil facial tumour disease.


Funding for seven CRCs announced

25 February, 2014

Minister for Industry Ian Macfarlane has announced almost $186 million in funding as part of the 16th CRC (Cooperative Research Centre) Program selection round. The government funding will create three new CRCs and extend four existing CRCs.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd